Women and Cancer Magazine

You do already subscribe, right?
Women & Cancer is the premier women's health and wellness magazine, delivering breaking news about topics critical to women making informed decisions about their own and their family's health and emphasizing cancer prevention, early detection, management, and survivorship.
Women&Cancer empowers women with regard to their own health and recognizes the unique role of women in the overall health of their family and friends. Published quarterly, news and other unique content is published daily on the Web site, and all past issues are archived for easy access, creating an in-depth women’s health resource on the Web. Many women are likely to manage their own treatment while continuing to care for their families; as well, women often provide care for a child, spouse, or relative diagnosed with cancer while continuing to manage households and careers.
Features on accessing the complicated medical system, breaking news on medical advances, and legislative issues are also covered. Each issue of Women & Cancer also includes inspiring stories of families and survivors and offers a frequently updated list of resources for patients and caregivers.
Women & Cancer is distributed in print and online at www.womenandcancermag.com. Subscriptions are available at www.cancerconsultants.com or [email protected]. Patients who sign up online are offered a free one-year subscription.
Plus (and this is the best part!) FREE, one-year subscriptions are provided compliments of EIF (Entertainment Industry Foundation).

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap